With reference to the Notice dated 30th May, 2022 convening 29th Annual General Meeting (AGM) of the Company to be held on Friday, the 30th day of September, 2022 at 10.00 am (IST), through Video Conferencing / Other Audio-Visual Means (‘VC/OAVM’). Kobo Biotech has submitted newspaper publication of corrigendum which was issued with respect to Item No.3 of the Notice and the Explanatory Statement. This is in compliance with the provision of above-mentioned regulations and for the information.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: